By Bhanvi Satija and Christy Santhosh (Reuters) -Websites selling compounded versions of popular weight-loss drugs from Novo ...
The Centers for Medicare & Medicaid Services just announced 15 new drugs it wants to lower the cost for including popular, ...
KRLD Radio Dallas on MSN1h
Nicotine pouches get FDA approval, with some calling them Gen Z's favorite weight loss hackLittle pouches of nicotine sold by the brand ZYN were given the green light for marketing this week through the U.S. Food and ...
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...
A new analysis finds nearly half of the compounded GLP-1 websites didn’t include information on adverse effects, warnings, ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
Zyn nicotine pouches loved by young people for their appetite-suppressing effects have officially been approved in the US.
In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...
Ozempic, an anti-diabetes medication, has gained popularity for its off-label use in weight loss among celebrities, despite ...
Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback